86944222 - PIRLINRING

Information

• Trademark
• 86944222

• Source

• Serial Number

  86944222

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  March 17, 2016
  8 years ago

• Transaction Date

  May 15, 2017
  7 years ago

• Status Date

  May 15, 2017
  7 years ago

• Published for Opposition Date

  August 16, 2016
  8 years ago

• Location Date

  October 11, 2016
  8 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  SAPPENFIELD, ANN ELIZA

• Attorney Name

  Matthew O. Brady

  Law Office Assigned Location Code

  N10

• Owners

  • WARNER CHILCOTT COMPANY, LLC

Case File Statements

• GS0051: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Case File Event Statements

• 5/15/2017 - 7 years ago

  10 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/15/2017 - 7 years ago

  9 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 10/11/2016 - 8 years ago

  8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/16/2016 - 8 years ago

  7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/16/2016 - 8 years ago

  6 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/27/2016 - 8 years ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/12/2016 - 8 years ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/27/2016 - 8 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/22/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 3/21/2016 - 8 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP